Erlotinib Tablet, Film Coated
Product Images NDC 63304-135

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Erlotinib (NDC 63304-135). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 01)

Chemical structure of Erlotinib hydrochloride, showing the molecular arrangement of its chemical components, including the core aromatic rings and functional groups associated with the active ingredient Erlotinib HCl.*

FDA Label Image

Figure 1 (Image 02)

A Kaplan-Meier curve illustrating progression-free survival probability over time in months for patients treated with Erlotinib compared to chemotherapy. The x-axis represents duration of progression-free survival in months, and the y-axis shows progression-free survival probability. The number of patients at risk at various time points is listed below the x-axis for both treatment groups.*

FDA Label Image

Figure 2 (Image 03)

A Kaplan-Meier survival curve showing overall survival probability over months for patients receiving Erlotinib versus placebo. The graph includes a table of the number of patients at risk for each group at different time points along the survival axis.*

FDA Label Image

Figure 3 (Image 04)

A Kaplan-Meier survival curve graph showing survival probability over time in months for patients using Erlotinib versus placebo. The graph includes survival probability on the vertical axis and overall survival in months on the horizontal axis, with sample sizes at risk for each group displayed below the x-axis.*

FDA Label Image

Figure 4 (Image 05)

A Kaplan-Meier survival curve chart comparing overall survival probability over months between a placebo group and an Erlotinib group. The x-axis shows overall survival in months up to 36 months, and the y-axis shows survival probability from 0 to 1. Below the chart is a table listing the number of patients at risk at various time points for both groups, with a note referencing Cox regression analysis and Log-Rank test results.*

FDA Label Image

Erlotinib 25 mg_30 Capsules (Image 06)

Label for Erlotinib Tablets 25 mg, film-coated oral tablets in a 30-count package. The label shows the product name and strength prominently, with 'Rx only' indicated. It includes a barcode and the Sun Pharmaceutical Industries, Inc. logo. The label also lists the distributor as Sun Pharmaceutical Industries, Inc., Cranbury, NJ, and manufacturer as Sun Pharmaceutical Industries Ltd., Gujarat, India.*

FDA Label Image

Erlotinib 100 mg_30 Capsules (Image 07)

The packaging label for Erlotinib Tablets 100 mg by Sun Pharmaceutical Industries, Inc. Features include a prominently displayed product name and strength, a quantity of 30 tablets, and a barcode. The back side of the top layer includes storage instructions, dosage reference, and manufacturer and distributor details with addresses in New Jersey, USA, and Gujarat, India.*

FDA Label Image

Erlotinib 150 mg_30 Capsules (Image 08)

Erlotinib Tablets 150 mg film-coated oral tablets packaging label from Sun Pharmaceutical Industries, Inc. The package contains 30 tablets and is labeled Rx only. The label features a magenta block highlighting the strength and includes distributor and manufacturer information with storage instructions at controlled room temperature.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.